Articles tagged with Genetic Testing
A challenge to Canada's Genetic Non-Discrimination Act could lead to widespread genetic discrimination if the law is overturned. The act protects genetic test information from being required in contracts or by employers and insurers.
A study found that multigene testing is more likely to identify disease-associated genetic variants than BRCA-only testing, but may reveal mutations of uncertain clinical significance. The shift reflects a growing acceptance of multigene panel tests as a more clinically useful option for patients and their relatives.
A new diagnostic technique has been successfully tested at the University of Bradford, allowing for the isolation of responses from S-cone photoreceptors. This breakthrough could help in the diagnosis of diseases such as Types 1 and 2 diabetes, glaucoma, and high blood pressure.
A team of scientists has established a pig model of Huntington's disease using genetic engineering technology, offering a practical way to test treatments. The pig model closely matches human symptoms and provides advantages over existing mouse models in terms of size and delivery of treatments.
A new study reveals that hybrid chickadees have marked deficiencies in learning and memory compared to their pure species parents. This discovery provides a new mechanism by which hybrids can have low fitness, potentially leading to cascading effects on species apart.
A new study reveals that mitochondrial disease patients often undergo more than eight physician visits and experience multiple misdiagnoses before being correctly diagnosed. The most common misdiagnosis was for psychiatric disorder, followed by fibromyalgia and chronic fatigue syndrome.
A new study published in PLOS Genetics has identified a mutation in the muskelin 1 gene that causes lethal acrodermatitis, a deadly skin condition in bull terriers. The discovery enables veterinarians to test for the disease and prevent breeding of affected dogs.
A recent study found that up to 40% of direct-to-consumer genetic tests provide incorrect readings in raw data. The findings highlight the importance of seeking clinical test validation to ensure accurate patient care.
Scientists developed a first laboratory test to pick up traces of manatee's genetic material in waterways. The innovative environmental DNA test can reveal whether one or more of the elusive marine mammals has been in the area within the past month.
A new study found that nearly half of women with breast cancer who should undergo genetic testing did not receive it. Genetic counselors were underutilized, with only half of those in the high-risk group receiving counseling before surgery.
The Genomic Ascertainment Cohort (TGAC) will allow researchers to recall genotyped individuals and investigate the influence of their genes and gene variants on phenotypes. The NIH will establish a new database of 10,000 human genomes and exomes, enabling predictions of conditions caused by specific genes or variants.
Researchers at the University of Melbourne identified 24 previously unknown epigenetic changes that alter a woman's risk of breast cancer and can be passed down through generations. These changes, related to DNA methylation, were found in only approximately 20% of women with familial breast cancer who underwent genetic testing.
The Association for Molecular Pathology (AMP) has published consensus-based recommendations for clinical CYP2C19 genotyping allele selection. The guidelines aim to standardize testing across laboratories and improve concordance, enabling better patient care.
Researchers found that patients at risk of inherited heart disease often don't understand the implications of genetic test results, leading to psychological and behavioral changes. This study highlights the need for better communication around cardiac genetic counseling prior to testing.
A global survey of genetic testing labs reveals inconsistent protocols for analyzing BRCA genes, which could impact cancer susceptibility. The study calls for global best-practice guidelines to ensure consistency in test results.
Researchers have developed a CRISPR-based diagnostic tool called SHERLOCK, which has been enhanced to detect multiple targets at once and show results on a paper strip. The new feature increases sensitivity 100-fold, allowing for the detection of low concentrations of genetic material in samples.
A new study from Ohio State University found that women whose family members or friends died of cancer are more likely to approach breast cancer prevention aggressively. Women with traumatic experiences perceive breast cancer as a death sentence, while those with positive experiences see it as a hardship that can be overcome.
The new guidelines update the 2013 recommendations to include genetic alterations driving lung cancer and new drugs to target these alterations. Testing for ROS1 in all cases of lung adenocarcinoma is now recommended, as well as using circulating tumor DNA and cytology specimens when tissue is unavailable.
Researchers at Mayo Clinic developed a new test that can establish which inherited BRCA2 gene mutations increase the risk of breast or ovarian cancer. The study identified 54 pathogenic mutations and expanded the list of neutral mutations, providing better decision-making options for patients with genetic testing results.
A genetic ancestry test more accurately identified patients at risk for bleeding stroke than traditional self-reports of race or ethnicity, according to a new study. The test was particularly effective in identifying four known risk factors for stroke, including diabetes and high blood pressure, in black and Hispanic populations.
A study by UNIGE and UNIL researchers found that individuals with Down syndrome have an excellent genome, better than the average genome of people without the genetic abnormality. This high-quality genome may compensate for the disabilities caused by the extra chromosome 21, enabling some fetuses to reach full term and grow up to old age.
A new mathematical tool, based on Bayes' Theorem, was developed to validate and improve methods for interpreting clinical genetic test results. The tool assessed the rigor of widely-used approaches and found that a system of 18 rules is statistically sound and objectively strong.
A new review examines the quality-of-life consequences of genetic testing and risk-reducing surgery, finding that procedures can decrease cancer anxiety but are associated with short- and long-term complications.
Researchers developed a new approach to detecting the cause of intracerebral hemorrhage (ICH), the deadliest form of stroke. Combining a blood test with a brain scan can accurately spot cerebral amyloid angiopathy (CAA), a condition linked to ICH and increased risk of further strokes and dementia.
The Genetic Information Nondiscrimination Act (GINA) created an individual access right to genomic data, but its implementation has been marred by controversy and conflicting regulations. Bioethicists and safety regulators have raised concerns about the misuse of genetic data, while lawmakers argue that GINA solves a non-existent problem.
A new study by MIT professor Catherine Tucker reveals that policies emphasizing patient control of genetic data lead to an increase in the number of tests performed, while those focusing on privacy risks result in a reduction. Researchers found that guarantees about data use had no effect.
A blood-based precision medicine test incorporating age, sex, and gene expression score (ASGES) helped evaluate older outpatients with symptoms of obstructive coronary artery disease. The study found higher incidence of major adverse cardiovascular events in those with high ASGES scores compared to low ASGES scores
Researchers identified an association between a specific SLC6A15 polymorphism and resting-state brain function in multiple brain regions in patients with MDD. The study suggests a potential genetic link to the development of major depressive disorder.
Researchers at Oregon State University found notable differences in the taste of beers malted from two barley varieties, revealing novel flavors that carry through malting and brewing into beer. The study's results have significant implications for the brewing industry, particularly for beer connoisseurs.
Adolescents display nuanced views on pediatric genetic testing for adult-onset conditions, with approximately half agreeing to defer testing. Students' opinions were influenced by the preventability of the condition, with those focused on early-onset diseases supporting deferral and those on preventable conditions opposing it.
A study analyzing BRCA testing trends from 2003 to 2014 found a significant spike in testing following the publication of Angelina Jolie's op-ed on gene testing. The test increased 80-fold, with rural areas showing higher follow-up surgical procedure rates compared to urban areas.
Researchers have discovered a new genetic signature for autism by analyzing the genomes of 516 autistic children and their families. The study found that individuals with autism are more likely to have multiple genetic variations, suggesting a complex interplay between genes in the development of the disorder.
A large-scale Canadian study found that nearly one percent of the population has elevated antibodies indicating celiac disease. Despite a strong genetic link to Caucasians, South Asian individuals were surprisingly affected by a specific genetic variant, suggesting other factors may play a role in who develops the disease.
Researchers used gene therapy to express melanopsin in mouse retinas, restoring visual function and improving pupil constriction. The treatment was effective for up to 15 months, showing enhanced visual responses and light avoidance behaviors.
A genetic test developed by UPMC scientists proved highly sensitive in detecting pancreatic cysts associated with aggressive pancreatic cancer. The test, PancreaSeq°, correctly classified patients with intraductal papillary mucinous neoplasm (IPMN) and identified cysts that would progress to cancer with 100% accuracy.
The partnership between genetic testing companies and orphan drug developers has both positive and negative implications. On the one hand, it can lead to faster diagnosis and treatment of rare diseases. However, there are also concerns over patient privacy and potential price-gouging due to rising healthcare costs.
A new study published in the Journal of the American Medical Association found that genetic testing can help set safe doses of common blood thinner warfarin. The study showed that patients who received warfarin dosing guided by their genetic makeup had a 27% reduction in adverse events, including bleeding and blood clots.
A new polygenic hazard score test combines 31 genetic variants and APOE E4 to predict Alzheimer's risk in cognitively normal older adults, outperforming traditional APOE E4 testing. The test identifies high-risk individuals with early cognitive decline and higher amyloid plaque levels.
Scheme Lab develops a portable DNA sequencing kit for rapid detection of genetic variations in meat quality, seedlings, and plants. The 'point-of-care' test can be used anywhere - in factories, on farms, or at home.
A new study by USC researchers suggests that the TOMM40 gene, neighboring ApoE4 on chromosome 19, has a significant influence on late-life development of dementia and Alzheimer's. The research found that a TOMM40 variant was more influential than ApoE4 in decline of immediate memory.
A recent study found 60 gene variants that affect hemoglobin A1c levels, including one variant unique to African Americans. This variant can reduce the accuracy of A1c blood testing, increasing the risk of underdiagnosis in a population already disproportionately affected by type 2 diabetes.
Two independent mouse studies found that ketogenic diets improved memory in older animals and increased their chances of living longer. The diets also preserved physical fitness and altered insulin signaling pathways in the mice. Further research is needed to fully understand the effects of a ketogenic diet on human health and aging.
The Association for Molecular Pathology (AMP) has awarded prestigious honors to Drs. Andrew P. Feinberg, Gregory J. Tsongalis, and Alexis B. Carter for their outstanding contributions to the field of molecular diagnostics. AMP President Federico A. Monzon praised the award recipients for their decades of service to the society.
Researchers developed a new assay to detect gene fusions in dozens of genes simultaneously, identifying a rare MET fusion in a late-stage lung cancer patient. The patient showed an almost complete response to targeted therapy crizotinib after over 8 months of treatment.
Researchers at the University of Basel developed a rapid test to diagnose Sp110 protein deficiency, a severe immune defect. The test uses flow cytometry to detect the presence of Sp110 protein in patient blood cells, enabling quick diagnosis in hours.
Despite high-risk genetic mutations detectable through simple blood or saliva tests, only 15% of affected women in US have taken recommended genetic test. A new study from UCLA Fielding School of Public Health highlights a significant unmet need for genetic testing across the country.
A new blood test can detect miniscule amounts of cancer DNA released into the blood, allowing for rapid detection of genetic mutations. This test has the potential to be personalized to recognize mutations unique to individual cancers.
A new study published in Neurology found that most newborns with epilepsy (83%) have identifiable genetic causes, which can help guide treatment and connect families with condition-specific support groups. Genetic testing can provide comfort and closure for families, allow for tailored treatment, and improve diagnostic outcomes.
A team of researchers has developed a simplified genetic toolkit to test hypotheses about the neural underpinnings of behavior in animals. The toolbox allows scientists to easily tailor the approach for any purpose and any species, overcoming limitations in traditional model organisms like fruit flies and mice.
A study published in JAMA Pediatrics found that genetic testing is effective in diagnosing epilepsy in 40% of patients and 25% of those with unknown causes. Genetic sequencing tests have a higher diagnostic yield than chromosome microarray, allowing for more precise treatment options.
Researchers developed a new type of sweat test that can overcome the challenge of ambiguous results in current tests. The test identifies alternative molecules found in sweat associated with CF, providing staging and prognostic information.
Researchers found that blocking molecular nerve pruning in mice enhanced manual dexterity and allowed them to grab and eat food faster than wild-type mice. The study identified a protein called PlexA1, which controls the formation of long nerves and fine motor skills.
Researchers discovered a single nucleotide polymorphism in the hepcidin promoter gene associated with increased susceptibility to extrapulmonary tuberculosis. This genetic variation leads to decreased hepcidin production, impairing macrophage function and allowing M. tuberculosis to spread to other areas of the body.
Researchers have developed a new class of NanoVelcro microchips that can capture and analyze rare circulating fetal cells in a mother's blood. This technology has the potential to noninvasively diagnose prenatal conditions, reducing the risk of miscarriage and harm to the fetus.
A new era in human genomic variation interpretation is underway, driven by the need for standardized and accurate clinical care. Data sharing has become increasingly important, with payers requiring labs that share data to be reimbursed.
Researchers at QUT have developed a new, genetically modified banana rich in pro-vitamin A, a crucial nutrient for fighting vitamin A deficiency. The project aims to improve the nutritional content of bananas in Uganda, where they are a staple food and lack essential micronutrients.
A molecular diagnostic test has received FDA approval for accurately distinguishing among the three most common causes of vaginitis. The test is more sensitive, faster, and objective than traditional methods, providing detailed diagnoses that can help determine the best course of treatment.
Researchers found that genetic testing can pick out men at increased risk of testicular cancer, who may benefit from monitoring or preventative treatment. Testing identified 1% of men at highest risk, with a 7% lifetime risk of developing the disease.
A new blood test has been identified to predict the onset and track the progression of Huntington's disease. The test measures neurofilament levels in the blood, which increase throughout the course of the disease, even in carriers of the genetic mutation.
A new study found that genetic variants on chromosome 3 are associated with better performance on the 'Reading the Mind in the Eyes' Test, which measures cognitive empathy. Women tend to score higher than men, and variations in the gene LRRN1 are linked to increased volume of the brain region involved in this skill.